Fundamental Problems in Breast Cancer: Proceedings of the Second International Symposium on Fundamental Problems in Breast Cancer Held at Banff, Alberta, Canada April 26–29, 1986: Developments in Oncology, cartea 51
Editat de Alexander H.G. Paterson, Alan W. Leesen Limba Engleză Hardback – 31 iul 1987
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1579.31 lei 6-8 săpt. | |
Springer Us – 18 oct 2011 | 1579.31 lei 6-8 săpt. | |
Hardback (1) | 1399.91 lei 6-8 săpt. | |
Springer Us – 31 iul 1987 | 1399.91 lei 6-8 săpt. |
Din seria Developments in Oncology
- 5% Preț: 354.68 lei
- 5% Preț: 378.36 lei
- 5% Preț: 345.71 lei
- 5% Preț: 1078.48 lei
- 5% Preț: 354.83 lei
- 5% Preț: 1106.88 lei
- 5% Preț: 3129.77 lei
- 5% Preț: 365.10 lei
- 5% Preț: 368.31 lei
- 5% Preț: 1393.97 lei
- 5% Preț: 369.06 lei
- 5% Preț: 362.40 lei
- 5% Preț: 1083.51 lei
- 5% Preț: 362.20 lei
- 15% Preț: 594.37 lei
- 5% Preț: 1401.69 lei
- 5% Preț: 1100.23 lei
- 5% Preț: 368.31 lei
- 5% Preț: 1392.18 lei
- 5% Preț: 711.04 lei
- 5% Preț: 701.34 lei
- 5% Preț: 1400.11 lei
- 5% Preț: 706.55 lei
- 5% Preț: 361.49 lei
- 5% Preț: 1399.20 lei
- 5% Preț: 1079.19 lei
- 5% Preț: 3771.24 lei
- 5% Preț: 1082.08 lei
- 5% Preț: 1100.90 lei
- 5% Preț: 1395.43 lei
- 5% Preț: 1415.01 lei
- 5% Preț: 1095.92 lei
Preț: 1399.91 lei
Preț vechi: 1473.59 lei
-5% Nou
Puncte Express: 2100
Preț estimativ în valută:
267.99€ • 275.62$ • 222.33£
267.99€ • 275.62$ • 222.33£
Carte tipărită la comandă
Livrare economică 19 februarie-05 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780898388633
ISBN-10: 0898388635
Pagini: 408
Ilustrații: XVIII, 408 p.
Dimensiuni: 155 x 235 x 24 mm
Greutate: 0.77 kg
Ediția:1987
Editura: Springer Us
Colecția Springer
Seria Developments in Oncology
Locul publicării:New York, NY, United States
ISBN-10: 0898388635
Pagini: 408
Ilustrații: XVIII, 408 p.
Dimensiuni: 155 x 235 x 24 mm
Greutate: 0.77 kg
Ediția:1987
Editura: Springer Us
Colecția Springer
Seria Developments in Oncology
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I. The natural history and clinical significance of breast cancer detected by imaging techniques.- 1. Pathology of breast cancer detected by imaging techniques.- 2. Screening for breast cancer: an overview.- 3. Research in new imaging methods for detection of breast cancer.- 4. The Canadian national breast screening study: current status.- 5. Natural history of mammary tumors seen in a breast center.- 6. An educational and diagnostic breast center in edmonton: a preliminary report of the first year.- 7. The Breast Center—a multidisciplinary model.- 8. Multimodality breast imaging: the value of diaphanography.- 9. Comparative value of diaphanoscopy, mammography, and thermography for breast cancer screening.- 10. Finding earlier nonpalpable breast cancers using hooked wire directed biopsy and a modified overpenetrated mammographic technique.- 11. The significance of tumor size in stage I invasive breast cancer.- 12. The impact of breast cancer screening on surgical treatment policies.- 13. Survival of patients with breast cancer detected between mammographic screenings.- 14. Intraductal breast carcinoma—what constitutes adequate treatment?.- II. Aspects of the growth and mechanism of response of endocrine sensitive breast cancer.- 15. Endocrine and other influences in the normal development of the breast.- 16. Endocrine prevention of breast cancer by tamoxifen.- 17. Mechanisms of regression and revised approaches to endocrine therapy.- 18. Growth factors, oncogenes, and breast cancer.- 19. Estrogenic recruitment followed by chemotherapy in breast cancer: experimental and clinical results.- 20. Relationship of breast cancer hormone receptors, menopausal status, and adjuvant therapy to site(s) of recurrence and survival.- 21. Cyclical use of tamoxifen and high-dosemedroxyprogesterone acetate in advanced breast cancer.- 22. An inverse relationship between intracellular prolactin and growth hormone and estrogen receptor status in human breast cancers.- 23. Steroid receptors in breast cancer: Kuwait experience.- III. Adjuvant systemic therapy: current clinical trials and aspects of statistical evaluation of adjuvant chemotherapy.- 24. Breast cancer trials of the Ludwig and International Breast Cancer Study Group.- 25. The validity of summing results of clinical trials in breast cancer.- 26. Cost-benefit analysis of chemotherapy trials.- 27. Adjuvant therapy in postmenopausal patients with operable breast cancer.- IV. Research on life quality and the effect of local and systemic therapy on quality of life.- 28. Autonomic insufficiency in patients with advanced breast cancer.- 29. Brachial plexopathy in patients with breast cancer.- 30. Lymphedema—its treatment.- 31. Competing causes of death in breast cancer patients.- 32. Breast cancer profile in India: experiences at the Tata Memorial Hospital, Bombay.- V. Laboratory research relevant to the management of patients with breast cancer over the next decade.- 33. Tumor metastasis: biology and experimental therapeutic approaches.- 34. The detection and evaluation of bone marrow micrometastases in primary breast cancer.- 35. Physiology of bone and metabolic approaches to the treatment of skeletal metastases.- 36. Expression of the ras oncogene p21 protein in human breast tumors and in several benign conditions using the y13 259 monoclonal antibody.- 37. Synergistic effect of cell kinetics-directed chemo-endocrine therapy on experimental mammary tumors.- VI. Future directions in the assessment, management, and treatment of the patient with breast cancer.- 38. The natural history ofhuman breast cancer: implications for patient management.- 39. Assessment of treatment in the clinic.- 40. Treatment of metastatic breast cancer as a guide to design of adjuvant therapy trials.- 41. Problems associated with the assessment of patients with metastatic breast cancer: can past experience teach us to do better clinical trials?.- 42. Preoperative combined modality (neoadjuvant) therapy for locally advanced inoperable breast cancer (LAIBC).- 43. Priorities in cancer control strategies in India.- 44. The epidemiology of breast cancer from an African perspective.- Summary: breast cancer in the eighties.